Cantor Starts Xenon Pharma (XENE) at Overweight, 'X Marks the Spot for Kv-Driven Leading Ion Channel Neuro-Innovator'
Tweet Send to a Friend
(Updated - April 25, 2023 6:33 AM EDT)
Cantor Fitzgerald analyst Charles Duncan initiates coverage on Xenon Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Charles Duncan initiates coverage on Xenon Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
